The human clinical trial gap: As of this writing, no published randomized, placebo-controlled human clinical trial has evaluated BPC-157 for any indication
This early response may reflect the body's immediate utilisation of available B12 for urgent metabolic processes
As a result of our review on OMIM, we identified 20 receptor genes as discussed in Methods : 8 GABA ( GABBR1,2 , GABRA1,5 , GABRB1-3 , GABRG2 ), 4 AMPA glutamate ( GRIA1-4 ), 6 NMDA glutamate ( GRIN1,A,2A-D ), 1 metabotropic glutamate ( GRM1 ), and 1 glycine ( GLRA1 )
Each component is associated in published preclinical literature with distinct mechanistic pathways, and the blend format allows laboratories to prepare all four under matched conditions for parallel single-agent and combined-arm experiments